Education
About Us
Working with TipRanks
Follow Us
MedinCell SA (FR:MEDCL)
:MEDCL
Total Valuation
MedinCell SA has a market cap or net worth of €839.54M. The enterprise value is €0.00.
Market Cap€839.54M
Enterprise Value€0.00
Share Statistics
MedinCell SA has 33,345,783 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding33,345,783
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MedinCell SA’s return on equity (ROE) is 1.13 and return on invested capital (ROIC) is -16.11%.
Return on Equity (ROE)1.13
Return on Assets (ROA)-0.20
Return on Invested Capital (ROIC)-16.11%
Return on Capital Employed (ROCE)-0.18
Revenue Per Employee194.97K
Profits Per Employee-140.75K
Employee Count131
Asset Turnover0.28
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of MedinCell SA is ―. MedinCell SA’s PEG ratio is 0.80.
PE Ratio―
PS Ratio16.41
PB Ratio-25.60
Price to Fair Value-25.60
Price to FCF23.54
Price to Operating Cash Flow38.39
PEG Ratio0.80
Income Statement
In the last 12 months, MedinCell SA had revenue of 25.54M and earned -18.44M in profits. Earnings per share was -0.63.
Revenue25.54M
Gross Profit25.54M
Operating Income-10.84M
Pretax Income-18.28M
Net Income-18.44M
EBITDA-11.20M
Earnings Per Share (EPS)-0.63
Cash Flow
In the last 12 months, operating cash flow was -17.10M and capital expenditures -782.00K, giving a free cash flow of -17.88M billion.
Operating Cash Flow-17.10M
Free Cash Flow-17.88M
Free Cash Flow per Share-0.54
Dividends & Yields
MedinCell SA pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.92
52-Week Price Change49.76%
50-Day Moving Average30.66
200-Day Moving Average20.46
Relative Strength Index (RSI)35.83
Average Volume (3m)179.66K
Important Dates
MedinCell SA upcoming earnings date is Jun 16, 2026, During Market Hours (Confirmed).
Last Earnings DateDec 9, 2025
Next Earnings DateJun 16, 2026
Ex-Dividend Date―
Financial Position
MedinCell SA as a current ratio of 2.70, with Debt / Equity ratio of -358.99%
Current Ratio2.70
Quick Ratio2.70
Debt to Market Cap0.13
Net Debt to EBITDA0.03
Interest Coverage Ratio-2.13
Taxes
In the past 12 months, MedinCell SA has paid 160.00K in taxes.
Income Tax160.00K
Effective Tax Rate>-0.01
Enterprise Valuation
MedinCell SA EV to EBITDA ratio is -37.39, with an EV/FCF ratio of 23.52.
EV to Sales16.40
EV to EBITDA-37.39
EV to Free Cash Flow23.52
EV to Operating Cash Flow21.51
Balance Sheet
MedinCell SA has €53.50M in cash and marketable securities with €58.27M in debt, giving a net cash position of -€4.77M billion.
Cash & Marketable Securities€53.50M
Total Debt€58.27M
Net Cash-€4.77M
Net Cash Per Share-€0.14
Tangible Book Value Per Share-€0.65
Margins
Gross margin is 100.00%, with operating margin of -42.44%, and net profit margin of -72.19%.
Gross Margin100.00%
Operating Margin-42.44%
Pretax Margin-71.56%
Net Profit Margin-72.19%
EBITDA Margin-43.85%
EBIT Margin-51.64%
Analyst Forecast
The average price target for MedinCell SA is €34.30, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€34.30
Price Target Upside36.22% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast166.31%
EPS Growth Forecast43.80%